See All Slides - tctmd.com

Slides

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Fundamentals of IVUS Acquisition and Analysis

Presenter: John Hodgson

October 24, 2012

Presentation TCT 2012

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

Multidisciplinary Approach to Mitral Valve Disease

Presenter: Neil Moat

October 24, 2012

Presentation TCT 2012

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Presenter: Gregg Rosner

October 24, 2012

Presentation TCT 2012

Multiple CTOs and a Calcified Critical Lesion After Failed CABG

Presenter: Wen-Lieng Lee

October 24, 2012

Presentation TCT 2012

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Design and Rationale of ISCHEMIA

Presenter: David Maron

October 24, 2012

Presentation TCT 2012

No: In This Case Even the Most Ingenious Percutaneous Approaches Are Doomed to Fall Short!

Presenter: Patrick McCarthy

October 24, 2012

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Advertisement

Slides

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Fundamentals of IVUS Acquisition and Analysis

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Multidisciplinary Approach to Mitral Valve Disease

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Multiple CTOs and a Calcified Critical Lesion After Failed CABG

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

Design and Rationale of ISCHEMIA

No: In This Case Even the Most Ingenious Percutaneous Approaches Are Doomed to Fall Short!

Tough Call During an LAA Occlusion

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content